Lupus erythematosus (subacute cutaneous lupus erythematosus (SCLE))
- (2012): Dalle Vedove C+, J Dtsch Dermatol Ges 10(12), 889 [REVIEW]
Adverse reactions attributed to entire drug class 'Taxane'
Please login to view adverse reactions.
- (2024): Yamamoto K+, Support Care Cancer 32(10), 647 [REVIEW]
- (2014): Prescrire Int 23(151), 180
- (2022): Morrison A+, Sci Rep 12(1), 11575
- (2015): Fernandes Kde A+, An Bras Dermatol 90(5), 728 (passim)
- (2023): Zhang J+, Expert Opin Drug Saf Mar, Online ahead of print
- (2022): Guijosa A+, Clin Transl Sci Jul, Online ahead of print [REVIEW] (pharmacogenomics)
- (2024): Mladosievicova B+, Bratisl Lek Listy 125(4), 207-210 [REVIEW] (pharmacogenomics)
- (2024): Schneider BP+, J Clin Oncol Jun, Online ahead of print
- (2021): Jablonická M+, Vnitr Lek 67(1), 26-31 [REVIEW]
- (2020): Pabst L+, Breast J Dec, Online ahead of print21% (9% grade 3)
- (2020): Chen E+, Ann Gastroenterol 33(1), 59
Hepatotoxicity / liver injury / acute liver injury / drug-induced liver injury (DILI)
- (2025): Cheng Y+, Sci Rep 15(1), 15137 [REVIEW] (pharmacovigilance / pharmacoepidemiology)
Neutropenia (neutrophils decreased)
- (2015): Fernandes Kde A+, An Bras Dermatol 90(5), 728 (passim)
- (2024): Tsujinaka H+, Sci Rep 14(1), 19530
- (2013): Makri OE+, Drugs 73(8), 789 [REVIEW]
- (2022): Ye YT+, Front Biosci (Landmark Ed) 27(6), 171 [REVIEW]
Adverse effects / adverse reactions
- (2015): Sharma A+, Perspect Clin Res 6(2), 10917%
